Phase I/II Trial of R115777 and XRT in Pediatric Patients With Newly Diagnosed Non-Disseminated Intrinsic Diffuse Brainstem Gliomas
Phase of Trial: Phase I/II
Latest Information Update: 05 Nov 2013
At a glance
- Drugs Tipifarnib (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use
- 05 Nov 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 05 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jan 2008 Status changed from recruiting to in progress.